Precision Optics Corporation, Inc. designs, develops, manufactures and sells specialized optical and illumination systems and related components. The Company manufactures products in two areas: medical products for use by hospitals and physicians, and products used by military and industrial customers. Its medical instrumentation line includes traditional endoscopes and endocouplers, as well as other custom imaging and illumination products for use in minimally invasive surgical procedures. It manufactures three dimensional (3D) endoscopes and small Microprecision lenses. The Company develops and sells endoscopes integrating various optical technologies, including its Lenslock technology, for use in a range of minimally invasive surgical and diagnostic procedures. The Company also designs and manufactures custom optical medical devices for its customers' specific requirements. It also manufactures and sells components and assemblies specially designed for industrial and military use.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Symbol: NASDAQ:PEYE
- CUSIP: N/A
- Web: www.poci.com/
- Trailing P/E Ratio:
- P/E Growth:
- Net Margins: -16.61%
- Return on Equity: -81.33%
- Return on Assets: -30.51%
Frequently Asked Questions for Precision Optics Co. (NASDAQ:PEYE)
What is Precision Optics Co.'s stock symbol?
Precision Optics Co. trades on the NASDAQ under the ticker symbol "PEYE."
How were Precision Optics Co.'s earnings last quarter?
Precision Optics Co. Inc (NASDAQ:PEYE) issued its earnings results on Monday, May, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $0.98 million during the quarter. Precision Optics Co. had a negative net margin of 16.61% and a negative return on equity of 81.33%. View Precision Optics Co.'s Earnings History.
When will Precision Optics Co. make its next earnings announcement?
Who are some of Precision Optics Co.'s key competitors?
Some companies that are related to Precision Optics Co. include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Valeant Pharmaceuticals Intl (VRX), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT), Cotiviti Holdings (COTV), WuXi PharmaTech (Cayman) (WX), Hikma Pharmaceuticals Plc (HIK) and Puma Biotechnology (PBYI).
Who are Precision Optics Co.'s key executives?
Precision Optics Co.'s management team includes the folowing people:
- Peter H. Woodward, Chairman of the Board, Director
- Joseph N. Forkey, President, Chief Executive Officer, Treasurer, Director
- Donald Andrew Major, Chief Financial Officer, Executive Vice President - Corporate Development
- Andrew J. Miclot, Director
- Kenneth S. Schwartz M.D., Director
- Richard B. Miles, Independent Director
How do I buy Precision Optics Co. stock?
MarketBeat Community Rating for Precision Optics Co. (NASDAQ PEYE)MarketBeat's community ratings are surveys of what our community members think about Precision Optics Co. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Shares of Precision Optics Co. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
Consensus Ratings for Precision Optics Co. (NASDAQ:PEYE) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Precision Optics Co. (NASDAQ:PEYE)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Precision Optics Co. (NASDAQ:PEYE)Earnings History by Quarter for Precision Optics Co. (NASDAQ PEYE)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/15/2017||Q3 2017||($0.02)||$0.98 million||View||N/A|
Earnings Estimates for Precision Optics Co. (NASDAQ:PEYE)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Precision Optics Co. (NASDAQ:PEYE)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Precision Optics Co. (NASDAQ:PEYE)Insider Trades by Quarter for Precision Optics Co. (NASDAQ:PEYE)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/22/2016||Hershey Strategic Capital, Lp||Major Shareholder||Buy||25,980||$0.60||$15,588.00|| |
|11/29/2016||Peter H Woodward||Director||Buy||156,667||$0.60||$94,000.20|| |
|1/26/2016||Stuart Sternberg||Major Shareholder||Sell||60,000||$0.50||$30,000.00|| |
|1/6/2016||Hershey Strategic Capital, Lp||Major Shareholder||Buy||27,520||$0.60||$16,512.00|| |
|12/31/2015||Hershey Strategic Capital, Lp||Major Shareholder||Buy||29,500||$0.63||$18,585.00|| |
|12/1/2015||Hershey Strategic Capital, Lp||Major Shareholder||Buy||49,000||$0.68||$33,320.00|| |
|11/24/2015||Awm Investment Company, Inc.||Major Shareholder||Sell||1,073,999||$4.00||$4,295,996.00|| |
|11/6/2015||Awm Investment Company, Inc.||Major Shareholder||Sell||59,500||$0.50||$29,750.00|| |
|11/3/2015||Awm Investment Company, Inc.||Major Shareholder||Sell||2,500||$0.50||$1,250.00|| |
|10/27/2015||Awm Investment Company, Inc.||Major Shareholder||Sell||133,214||$0.56||$74,599.84|| |
|10/22/2015||Hershey Strategic Capital, Lp||Major Shareholder||Buy||37,313||$0.67||$24,999.71|| |
|10/22/2015||Peter H Woodward||Director||Buy||87,313||$0.67||$58,499.71|| |
|9/28/2012||Austin W & Greenhouse Da Marxe||Major Shareholder||Buy||611,112||$0.90||$550,000.80|| |
|9/28/2012||Donald Andrew Major||EVP||Buy||27,778||$0.90||$25,000.20|| |
|9/28/2012||Joseph Norman Forkey||CEO||Buy||22,223||$0.90||$20,000.70|| |
|9/28/2012||Richard B Miles||Director||Buy||11,112||$0.90||$10,000.80|| |
Headline Trends for Precision Optics Co. (NASDAQ:PEYE)
Latest Headlines for Precision Optics Co. (NASDAQ:PEYE)
Precision Optics Co. (PEYE) Chart for Thursday, August, 17, 2017